Evidence 360 Summit
RWE, Market Access & Pricing
Bringing together senior leaders across real-world evidence, market access, health economics and outcomes research (HEOR), payers, and pricing & reimbursement to explore the next generation of evidence-driven healthcare decision-making.
Event Overview
The 3rd Annual Evidence 360 Summit — RWE, Market Access & Pricing, hosted by Veridon Global, will take place on 11–12 March 2027 in Basel, Switzerland. It will bring together leading decision-makers representing pharma, biotech, RWE, HEOR, HTAs, payers, pricing & reimbursement groups, academia, and technology.
This year's edition focuses on integrating an innovative approach to evidence generation and the access journey. Instead of treating RWE, HEOR, Market Access, and Pricing as isolated activities, we explore how they align across early development, launch, reimbursement, and post-launch evidence.
Key discussions will examine evolving European evidence requirements driven by changing HTA practices, demand for comparative real-world evidence, payer expectations, and value demonstration beyond clinical endpoints.
The summit emphasizes the practical connection between evidence generation and market access outcomes—helping teams design, evaluate, and leverage evidence to influence pricing, reimbursement, and patient access.
Send an Enquiry
Have questions? Fill in your details below.
Connecting Evidence Generation to Real Market Access Outcomes
The agenda will feature practical pharma case studies, payer and HTA perspectives, interactive panel discussions, and expert-led sessions bringing together stakeholders across the entire evidence-to-access journey.
Evidence 360 Summit at a Glance
Key Areas of Focus
The programme for 2027 includes important trends in:
Why Basel?
Basel provides an ideal venue for a real-world evidence and market access meeting in Europe as it is home to an abundance of pharmaceutical, biotech, HEOR, market access and life sciences organisations. It allows us to have access to a unique European pharma and payer community bridging the Swiss, German and French life science ecosystems. Basel allows us to create a more diverse regional audience while keeping the senior-focused, tightly-packed nature of the Evidence 360 Summit intact.
Who Should Attend
The summit is targeted at senior professionals working in: Pharmaceutical & Biotechnology areas like-
Why Attend
Exclusive Insights
Latest advances in real-world evidence, market access, and pricing strategy.
Collaboration
Connect with pharma, payer, and HEOR leaders.
Access Strategies
Explore value-based pricing, innovative contracting, and reimbursement models.
RWE Integration
Real-world data generation, outcomes research, and evidence-based decision-making.
Regulatory Trends
Updates on global frameworks for market access and HTA processes.
2027 Edition Speakers
From Market Access Leaders to Real-World Evidence Pioneers
Join an exceptional lineup of leading experts and industry innovators advancing the future of evidence-based healthcare decision-making. The 2027 edition brings together influential voices from pharmaceutical and biotech companies, payer organizations, HTA bodies, and academic research centers—covering the full spectrum of real-world evidence, market access, pricing, and HEOR.
Catherine O'Sullivan
VP RWD
John Purdy
Population Health Strategy Lead – Immunology
Varun Gupta
Director, Value and Access, International, YTB, Immunology
Sandip Kiri
Head, Health Economics and HTA Evidence, Global Payer Value Strategy
Najib Slassi
Commercial Director, Gene Therapy & Rare Diseases, Europe
Alexandros Sagkriotis
RWDS Lead
Vivian Mendonca
Former Global Head, Menarini Group & Founder
Claire Cotton
Senior Consultant, Policy, Access & Evidence Strategy
Reya Sharma
Senior Manager, HEOR
Amer Omar
International & Partners Markets
Ece Parali Gülnar
Director, Pricing & Market Access, Emerging Markets
Henrike Ch. Plate
Global Market Access Strategy Lead, Early Portfolio
Elisabeth Brock
Owner
Annette Beiderbeck
Former Head, Market Access EMEA Neurology
Divya Sheshagiri
Global Director, RWE & Innovative Evidence
Bengt Anell
Senior Manager, Market Access, Nordics & BeNelux
Sandra Erntoft Idemyr
Founder
Agenda
REAL-WORLD EVIDENCE: GENERATION, STRATEGY & DATA-DRIVEN DECISION-MAKING
| Time | Session |
|---|---|
| 8:00 — Registration and Refreshments | |
| 8:50 | Welcome Note by Veridon Global |
| 8:55 | Opening Address by the Chairperson |
| SESSION 1: REAL-WORLD EVIDENCE GENERATION & STRATEGY | |
| 9:00 | Building a Fit-for-Purpose RWE Strategy Across the Product Lifecycle |
| 9:25 | Real-World Data Sources: Quality, Access & Interoperability |
| 9:50 | Leveraging RWE to Support Regulatory & HTA Submissions |
| 10:15 | Morning Refreshments, Poster Presentations & One-to-One Networking Meetings |
| 10:45 | Patient-Reported Outcomes & Real-World Effectiveness Studies |
| 11:10 | AI & Advanced Analytics in Evidence Generation |
| 11:35 | Panel Discussion: The Future of Real-World Evidence — What Will Define the Next Decade? |
MARKET ACCESS & PRICING: VALUE, PAYER STRATEGY & GLOBAL ACCESS
| Time | Session |
|---|---|
| 8:30 — Registration & Morning Coffee | |
| 8:55 | Opening Remarks by the Chairperson |
| SESSION 2: MARKET ACCESS, PRICING & PAYER STRATEGY | |
| 9:00 | Global Pricing & Reimbursement: Navigating Cross-Country Access |
| 9:25 | Value-Based Pricing & Innovative Contracting Models |
| 9:50 | Payer & HTA Perspectives: What Evidence Really Moves Decisions |
| 10:15 | Networking Break & One-to-One Partnering Meetings |
| 10:45 | Market Access Readiness for Emerging Therapies |
Download the full agenda to view all sessions, panel discussions, and networking slots.
Our Esteemed Sponsors & Partners
Supported by global pharmaceutical leaders, payer organizations, HEOR consultancies, and market access innovators shaping the future of evidence-based healthcare decision-making.
Thought Leadership Partner
Media Partners
Collaborating with global life sciences publications, clinical intelligence platforms, and healthcare media outlets for the 3rd Annual Evidence 360 Summit 2027.
Past Sponsors
Trusted by industry pioneers and global pharmaceutical, payer, and market access leaders from previous editions.
Why Sponsor?
Maximize your brand influence, present groundbreaking research, and form valuable commercial partnerships with top-tier decision-makers.
Dedicated Prime Speaking Slot
Exhibition Opportunity
One-to-One Meetings
Pre-Qualified Leads
High-Level Networking
Brand Impact
Glimpses Of Our Past Edition
Highlights from high-level keynotes, interactive panel debates, and strategic networking sessions.
What Leaders Say About Evidence 360
Insights and experiences from real-world evidence directors, academic leaders, and health research pioneers.
"Well done on organising the day successfully and thanks for inviting me over. Many thanks for the photos too! I hope you can have a good break soon! I am on my way back to Bristol now."
"It was an excellent conference, good location."
"I really enjoyed the summit and I would be more than happy to present next year with findings of our research, and recommend it to fellow colleagues in cancer research and in RWE/HEOR/MA. I found the sessions useful in terms of their breadth and being able to connect with a diverse range of attendees. John Purdy was an excellent Chair, the venue team was approachable and helpful, and the refreshments provided were excellent."
Join Us in Basel, Switzerland
Nestled at the border of Switzerland, Germany, and France, Basel is Europe’s beating heart for pharmaceutical innovation, payer strategy, and global market access.
Grand Conference Plenary Hall
Pullman Basel Europe
Situated right in the heart of Basel just footsteps away from Messe Basel, Pullman Basel Europe provides world-class plenary halls, high-tech audiovisual production, and landscaped garden terraces perfect for high-level partnering and executive networking.
Contact Our Team Today
Where collaborations spark and the future of real-world evidence and market access innovation begins.
For Speaking & Partnerships
Nikita Patankar Parab
Founder, Managing Director
nikita@veridonglobal.com